about
Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptorsUnderstanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biologyE-type prostanoid receptor 4 (EP4) in disease and therapySerum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients.Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure.Opposing roles of prostaglandin D2 receptors in ulcerative colitisThe myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitorsAnti-psoriatic therapy recovers high-density lipoprotein composition and function.O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.A biased non-Gαi OXE-R antagonist demonstrates that Gαi protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE.Aging affects high-density lipoprotein composition and function.Restoration of renal function does not correct impairment of uremic HDL propertiesCardiovascular complications in inflammatory bowel disease.Uremia alters HDL composition and functionEP4 receptor stimulation down-regulates human eosinophil function.Cyanate is a novel inducer of endothelial icam-1 expression.Dialysis Modalities and HDL Composition and FunctionHigh-Density Lipoprotein Function in Exudative Age-Related Macular DegenerationPlasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function.Protein carbamylation renders high-density lipoprotein dysfunctional.Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure PatientsModification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.Psoriasis alters HDL composition and cholesterol efflux capacityOxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein functionActivated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung.Refined purification strategy for reliable proteomic profiling of HDL2/3: Impact on proteomic complexity.Inflammation alters HDL composition and function: implications for HDL-raising therapies.The Role of PGE2 in Alveolar Epithelial and Lung Microvascular Endothelial Crosstalk.α/β Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate.2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis.Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.Liver disease alters high-density lipoprotein composition, metabolism and function.Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activationThe GPR55 antagonist CID16020046 protects against intestinal inflammation.Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein.
P50
Q24306707-C28BBC1F-69AD-458E-9591-C1637945DF06Q26827400-AEE7E317-A200-417B-B976-30D8580DD6E4Q26851156-188C2E2D-8A3C-4BCF-AF3A-AC66811AD681Q33572720-CF554B19-3DFA-4747-9F3A-0DA3EF790E91Q33681949-C4351F61-CF52-41BD-9EFF-E4A4F7614711Q33911390-4B7443B6-7E84-493C-AD0A-1749CB0187A9Q34001819-6236A881-032E-42C7-BC15-13B9B5D2C275Q34178582-118C5FB4-82C2-4CC8-AA98-6533CB735EA9Q34259215-F81323F7-422A-4E3F-BE65-2F53E20E7ABAQ34298903-12F5EF2B-E53C-4CCF-869D-6D1F842D1934Q34368772-6DC66706-DC00-4C17-99A2-0F54308C916DQ34415252-B90A738E-E6E7-49C9-8349-125180DA2B5DQ34781392-4D173113-43B1-4825-94ED-7CC7A669B48AQ35124223-FD7CF16A-B8B3-494F-95E3-1FDBCFD05CE2Q35197222-EB20BBE3-ED31-45B6-95B7-EDA46AF17A7DQ35210194-6F0DC214-14CF-4773-9727-2ECBC7393A92Q35332774-75CA36C7-A5A5-4315-8EFF-6A53716B7598Q35567375-47D8EEF0-7D6A-463C-B9DD-A1A27390A76BQ36003077-2B6F44AF-4349-4C21-A1BB-584CDC0E292AQ36015473-E7A215AB-CCA2-4B67-85BC-932D679F8989Q36032978-5D8749F4-C59C-499B-B4A6-2FB35067279EQ36036213-C92895D1-235B-4A05-9BEC-3FE41FD27DFCQ36050583-6D0D1D72-4F79-4AE2-A8E6-3836388BC92EQ36052803-7E6ABE74-526B-4471-ABD2-15112772B30EQ36477710-651DC0A5-BE5A-4E29-808C-813A5CAD7390Q36520321-E7E072E8-B59A-462D-A0FE-812273C2FE7EQ36611294-88CD61F4-968E-4C43-9327-43F733FBFC2FQ36681188-7C9D78E9-339F-4BDA-8313-44984104A588Q36681220-D14D8B55-E183-43FD-9C5E-F0C6277FAE8FQ37112098-2A6B5795-3EC4-4AD3-9E04-37299FFEB06EQ37472192-FC21E822-D2BB-4E6A-A169-A86EB25DEE35Q38068018-5CD8572D-2910-4EF1-8533-D6106A338A73Q38628132-7772C858-4F7F-441D-9A70-C170BBB679A2Q40404245-AB52570F-CE73-45EB-AEC5-7A1AD241A38BQ40498512-E19590CF-6343-4AA9-9085-4C52703CD326Q40518328-79B1D0E5-44CF-4130-B102-4322CBBEED91Q41231925-C43C0A68-7F3D-4CB8-A056-D8D586978527Q41387814-EFB4A9B5-8E17-4F7B-AB03-1BFF1423ABE4Q41638096-7E59AC95-8BAB-4FBB-B8EA-871F4A678BE8Q41987920-29EA6A03-95B8-458F-9EAF-1EC734383977
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gunther Marsche
@ast
Gunther Marsche
@en
Gunther Marsche
@es
Gunther Marsche
@nl
Gunther Marsche
@sl
type
label
Gunther Marsche
@ast
Gunther Marsche
@en
Gunther Marsche
@es
Gunther Marsche
@nl
Gunther Marsche
@sl
prefLabel
Gunther Marsche
@ast
Gunther Marsche
@en
Gunther Marsche
@es
Gunther Marsche
@nl
Gunther Marsche
@sl
P106
P1153
6507043582
P21
P2798
P31
P3835
gunther-marsche
P496
0000-0002-2422-5381